The liver regenerative effect of KY19334 is attributed to the control of cytosolic CXXC5 function, as confirmed by the similar increases in Lgr5+ cells in Cxxc5−/− mice with NASH induced by an identical model system (Supplementary Fig. 5a–f). This evidence concerns the gene LGR5 and metabolic dysfunction-associated steatohepatitis.